The eyePlate device: A groundbreaking solution for advanced glaucoma
Glaucoma is a leading cause of irreversible blindness, affecting over 700,000 people in the UK and 80 million globally. For those with advanced or aggressive forms of the disease, treatment options have often been limited, particularly when conventional therapies have proven insufficient. However, a pioneering device, the eyePlate, is changing the landscape of glaucoma treatment and providing new hope for patients with difficult-to-manage eye pressure.